A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia

被引：0
|
作者：
Niknam, Z. [1 ]
Fadaii, F. [1 ]
机构：
[1] Univ Social Welf & Rehabil, Tehran, Iran
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2009年 / 285卷
关键词：
D O I：
10.1016/S0022-510X(09)71067-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S280 / S281
页数：2
相关论文
共 50 条
  • [31] Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    Amiaz, Revital
    Fostick, Leah
    Gershon, Ari
    Zohar, Joseph
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (06) : 455 - 461
  • [32] Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-over study
    Altamura, AC
    Di Rosa, A
    Ermentini, A
    Guaraldi, GP
    Invernizzi, G
    Rudas, N
    Tacchini, G
    Pioli, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 155 - 159
  • [33] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia (vol 51, pg 349, 2002)
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    BIOLOGICAL PSYCHIATRY, 2002, 51 (12) : 1014 - 1014
  • [34] DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL OF CISAPRIDE IN POSTGASTRECTOMY PATIENTS WITH DUODENOGASTRIC REFLUX (DGR)
    VAEZI, M
    SEARS, R
    RICHTER, J
    GASTROENTEROLOGY, 1995, 108 (04) : A249 - A249
  • [35] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [36] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Otmar Bayer
    Tatiana Brémová
    Michael Strupp
    Katharina Hüfner
    Journal of Neurology, 2018, 265 : 291 - 298
  • [37] Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
    Segev, Aviv
    Evans, Anthony
    Hodsoll, John
    Whiskey, Eromona
    Sheriff, Rebecca S.
    Shergill, Sukhi
    MacCabe, James H.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 101 - 107
  • [38] A double-blind, cross-over comparison of the effects of amantadine or placebo-on visuomotor and cognitive function in medicated schizophrenia patients
    Silver, H
    Goodman, C
    Isakov, V
    Knoll, G
    Modai, I
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (06) : 319 - 326
  • [39] Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial
    Mainz, Jochen G.
    Schiller, Isabella
    Ritschel, Christiane
    Mentzel, Hans-Joachim
    Riethmueller, Joachim
    Koitschev, Assen
    Schneider, Gerlind
    Beck, James F.
    Wiedemann, Baerbel
    AURIS NASUS LARYNX, 2011, 38 (02) : 220 - 227
  • [40] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER TRIAL OF PROGABIDE AS ADD-ON THERAPY IN EPILEPTIC PATIENTS
    DEPASQUET, EG
    SCARAMELLI, A
    DECACERES, MP
    LHERITIER, C
    FELDMAN, S
    SANTANA, R
    AGUILAR, J
    MUSCH, B
    MORSELLI, PL
    EPILEPSIA, 1991, 32 (01) : 133 - 139
12345